9 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
#Diagnosis #Hematology ... CHADS2VASc #HASBLED #Comparison ... Stroke #Bleed #Anticoagulation ... #AFib
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
Hypertension 1 A2 Age ... disease 1 A Age ... CHADS2VASc #HASBLED #Comparison ... #AFib #Diagnosis ... #Hematology
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
, Creat > 1.5, Age ... AFib: CrCl 15-50 ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology
Symptoms Distinguishing Groups of Cutaneous Drug Reactions
IgE-mediated reactions:
 • Onset minutes to hours into treatment course
to hours into treatment ... Onset days into treatment ... to weeks into treatment ... Drug #Reactions #dermatology ... #clinical #comparison
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... and rivaroxaban are ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
useful when A-fib ... with digoxin, are ... #Fibrillation #AFib ... Medications #management #treatment ... #comparison #table
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... Risk factors: Age ... : No • Treatment ... Transfusion #Reactions #hematology ... #diagnosis #comparison
Scleroderma Like Conditions - Differential Diagnosis
Eosinophilic Fasciitis:
 - Orange peel induration (peau d'orange) of proximal extremities
glucocorticoids are ... the mainstay of treatment ... Differential #Diagnosis #comparison ... #table #dermatology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
PV, MDS, CML) Treatment ... • Treatment is ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... Thrombocythemia #ET #hematology